PROState Pathway Embedded Comparative Trial: The IP3-PROSPECT study

INTRODUCTION: The traditional double blind RCT is the ‘gold standard’ trial design. For a variety of reasons, these designs often fail to accrue enough participants to conclude. This is particularly challenging in localized prostate cancer. The cohort multiple randomised controlled trial (cmRCT) tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Bass, E.J., Klimowska-Nassar, N., Sasikaran, T., Day, E., Fiorentino, F., Sydes, M.R., Winkler, M., Arumainayagam, N., Khoubehi, B., Pope, A., Sokhi, H., Dudderidge, T., Ahmed, H.U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451266/
https://www.ncbi.nlm.nih.gov/pubmed/34139356
http://dx.doi.org/10.1016/j.cct.2021.106485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451266/
https://www.ncbi.nlm.nih.gov/pubmed/34139356
http://dx.doi.org/10.1016/j.cct.2021.106485

Ejemplares similares